You are here
The content on this page and other TGA archive pages is provided to assist research and may contain references to activities or policies that have no current application. See the full archive disclaimer.
TGA presentation: Wearable Technologies Conference, 7 December 2017
Presentation: Wearable Technologies Conference, Sydney
These presentation papers are provided on the TGA's website solely for the purpose of indicating or suggesting what TGA representatives spoke about to the various conferences and seminars to which it relates. The papers are not legislative in nature and should not be taken to be statements of any law or policy in any way.
The Australian Government Department of Health (of which the TGA is a part) advises that (a) the presentation papers should not be relied upon in any way as representing a comprehensive description of regulatory requirements, and (b) cannot guarantee, and assumes no legal liability or responsibility for, the accuracy, currency or completeness of the information contained in the presentation paper.
- Presented by: Dr Lee Walsh
- Presented at: Wearable Technologies Conference, Sydney
- Presentation date: 7 December 2017 (Conference was 7-8 Dec 2017)
- Presentation summary: Complying with Wearable Health Device Regulation
- Which devices does the TGA regulate?
- How are devices approved?
- How does the TGA regulate devices once they are on the market?
Complying with Wearable Health Device Regulation
Dr Lee Walsh
Senior Engineer, Biomaterials and Engineering Section
Wearable Technologies Conference, Sydney, 7 December 2017
Slide 1 - Overview of the TGA
- Part of the Australian Government Department of Health
- Administers the Therapeutic Goods Act 1989
- Main offices in Canberra – satellite offices in Sydney, Melbourne, Adelaide and Brisbane
- Operations cost recovered from industry
- Mission: To safeguard and enhance the health of the Australian community through the effective and timely regulation of therapeutic goods
Slide 2 - Overview of the TGA – What we do
- Evaluate therapeutic goods before they are supplied
- Focus on safety, quality and performance
- Monitor products once they are on the market
- Allow for access to unapproved goods in certain circumstances
- Provide input to therapeutic goods standards
- We do not make decisions based on value for money or make decisions about which products receive Government subsidy
Slide 3 - Who does this work?
Approximately 750 staff made up of:
- Biomedical scientists
- Medical officers
- Administrative staff
Slide 4 - The legislation
The TGA makes decisions based upon:
- Therapeutic Goods Act 1989
- Therapeutic Goods Regulations 1990
- Therapeutic Good (Medical Devices) Regulations 2002
Available on www.legislation.gov.au
- Therapeutics Goods Orders (TGO)
- Excluded Goods Orders
- Medical Device Standards Orders (MDSO)
- Conformity Assessment Standards Orders (CASO)
Available on www.tga.gov.au
Slide 5 - Is my wearable device regulated by the TGA?
41BD What is a medical device
- A medical device is:
(a) any instrument, apparatus, appliance, material or other article (whether used alone or in combination, and including the software necessary for its proper application) intended, by the person under whose name it is or is to be supplied, to be used for human beings for the purpose of one or more of the following:
- diagnosis, prevention, monitoring, treatment or alleviation of disease;
- diagnosis, monitoring, treatment, alleviation of or compensation for an injury or disability;
- investigation, replacement or modification of the anatomy or of a physiological process;
- control of conception;
and that does not achieve its principal intended action in or on the human body by pharmacological, immunological or metabolic means, but that may be assisted in its function by such means; or
(aa) any instrument, apparatus, appliance, material or other article specified under subsection (2A); or
(ab) any instrument, apparatus, appliance, material or other article that is included in a class of instruments, apparatus, appliances, materials or other articles specified under subsection (2B); or
(b) an accessory to an instrument, apparatus, appliance, material or other article covered by paragraph (a), (aa) or (ab).
(2A) The Secretary may, by notice published in the Gazette or on the Department's website, specify a particular instrument, apparatus, appliance, material or other article for the purposes of paragraph (1)(aa). The notice is not a legislative instrument.
(2B) The Secretary may, by legislative instrument, specify a particular class of instruments, apparatus, appliances, materials or other articles for the purposes of paragraph (1)(ab).
- For the purposes of paragraph (1)(a), the purpose for which an instrument, apparatus, appliance, material or other article (the main equipment) is to be used is to be ascertained from the information supplied, by the person under whose name the main equipment is or is to be supplied, on or in any one or more of the following:
- the labelling on the main equipment;
- the instructions for using the main equipment;
- any advertising material relating to the main equipment;
- technical documentation describing the mechanism of action of the main equipment.
- The Secretary may, by order published in the Gazette or on the Department's website, declare that a particular instrument, apparatus, appliance, material or other article, or that a particular class of instruments, apparatus, appliances, materials or other articles, are not, for the purposes of this Act, medical devices.
Is it a medical device as defined by the TG Act?
Slide 6 - My tech is a medical device, what now?
Australian regulatory guidelines for medical devices (ARGMD)
- Available on www.tga.gov.au
- Currently under review
- Australian Register of Therapeutic Goods (ARTG)
- Risk based regulation
- Essential Principles
- Quality System
Slide 7 - Risk based regulation and classification
Higher risk devices receive higher scrutiny
Therapeutic Goods (Medical Device) regulations 2002, Schedule 2
Slide 8 - Inclusion on the ARTG
Text version of OTC application placement flowchart
This text representation of this flowchart is provided as a list with numbered steps.
- Sponsor (go to step 2 or 3)
- Submit application for class 1 IVD or Class 1 (not IVD): Auto inclusion - end flowchart
- Manufacturer Evidence (Except for Class 1 IVD/Class1): Submit application for ARTG inclusion
- Pay application fee
- Application effective?
- YES: Go to step 6
- NO: End flow chart
- YES: Go to step 7
- NO: Go to step 12
- TGA requires information and audit fee (if applicable)
- Application lapses if fee not paid or information not provided
- Audit assessment
Slide 9 - My device is included in the ARTG, am I done?
Incident Report Investigation Scheme (IRIS)
- Sponsor must report the details of events associated with their devices that have, or could have resulted in serious injury or death – TG (MD) Regs 2002
Text version of Incident Report Investigation Scheme (IRIS) flowchart
This text representation of the IRIS flowchart is provided as a list with numbered steps.
- Assest Risk (go to step 2)
- Investigate (go to step 3 or 7)
- Referral and Laboratory testing (leads to product improvement)
- Regulatory action (go to step 5 or 6)
- Other action (leads to product improvement)
- Recall, Safety alert, Report, Cancel or suspend (each of these actions leads to step 7)
- Data logged for ongoing monitoring
Each step leads to overall Product improvement
Slide 10 - Other considerations
TGA can approve the supply of unregistered therapeutic goods
- Authorised prescribers
- Special access scheme
- Clinical trials
- Personal importation
- See www.tga.gov.au
There are penalties for (TG Act 1989, Part 4-11):
- Supplying a medical device that does not comply with the Essential Principles
- Not applying conformity assessment procedures
- Supplying a medical device that is not included in the register
There are advertising and labelling requirements (TG Act 1989, Chapter 5)
Slide 11 - The Essential Principles
Therapeutic Goods (Medical Devices) Regulations 2002, Schedule 1
- A legislated requirement for medical devices (TG Act 1989, Section 41CA)
- Used in pre-market evaluations
- Used in post market monitoring
- Standards may or may not be sufficient to demonstrate compliance
TGA assessors will assess your device against the Essential Principles
You should assess your device against the Essential Principles
You should consider the Essential Principles at every stage of you medical device’s life
Slide 12 - The Essential Principles
Therapeutic Goods (Medical Devices) Regulations 2002, Schedule 1
- Use of medical devices not to compromise health and safety
- Design and construction of medical devices to conform to safety principles
- Medical devices to be suitable for intended purpose
- Long-term safety
- Medical devices not to be adversely affected by transport or storage
- Benefits of medical devices to outweigh any side effects
Principles about design and construction
- Chemical, physical and biological properties
- Infection and microbial contamination
- Construction and environmental properties
- Medical devices with a measuring function
- Protection against radiation
- Medical devices connected to or equipped with an energy source
- Information to be provided with medical devices
- Clinical evidence
- Principles applying to IVD medical devices
*Large file warning: Attempting to open large files over the Internet within the browser window may cause problems. It is strongly recommended you download this document to your own computer and open from there.